Literature DB >> 1372524

c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas.

Y Funasaka1, T Boulton, M Cobb, Y Yarden, B Fan, S D Lyman, D E Williams, D M Anderson, R Zakut, Y Mishima.   

Abstract

The proto-oncogene c-Kit, a transmembrane receptor tyrosine kinase, is an important regulator of cell growth whose constitutively active oncogenic counterpart, v-kit, induces sarcomas in cats. Mutations in murine c-kit that reduce the receptor tyrosine kinase activity cause deficiencies in the migration and proliferation of melanoblasts, hematopoietic stem cells, and primordial germ cells. We therefore investigated whether c-Kit regulates normal human melanocyte proliferation and plays a role in melanomas. We show that normal human melanocytes respond to mast cell growth factor (MGF), the Kit-ligand that stimulates phosphorylation of tyrosyl residues in c-Kit and induces sequential phosphorylation of tyrosyl residues in several other proteins. One of the phosphorylated intermediates in the signal transduction pathway was identified as an early response kinase (mitogen-activated protein [MAP] kinase). Dephosphorylation of a prominent 180-kDa protein suggests that MGF also activates a phosphotyrosine phosphatase. In contrast, MGF did not induce proliferation, the cascade of protein phosphorylations, or MAP kinase activation in the majority of cells cultured from primary nodular and metastatic melanomas that grow independently of exogenous factors. In the five out of eight human melanoma lines expressing c-kit mRNAs, c-Kit was not constitutively activated. Therefore, although c-Kit-kinase is a potent growth regulator of normal human melanocytes, its activity is not positively associated with malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372524      PMCID: PMC275519          DOI: 10.1091/mbc.3.2.197

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  81 in total

1.  The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus.

Authors:  E Huang; K Nocka; D R Beier; T Y Chu; J Buck; H W Lahm; D Wellner; P Leder; P Besmer
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

Review 2.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

3.  Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms.

Authors:  D M Anderson; S D Lyman; A Baird; J M Wignall; J Eisenman; C Rauch; C J March; H S Boswell; S D Gimpel; D Cosman
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

4.  The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor.

Authors:  R Rottapel; M Reedijk; D E Williams; S D Lyman; D M Anderson; T Pawson; A Bernstein
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

5.  Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth.

Authors:  K Matsumoto; H Tajima; T Nakamura
Journal:  Biochem Biophys Res Commun       Date:  1991-04-15       Impact factor: 3.575

6.  Tyrosine phosphorylation of a 120-kilodalton pp60src substrate upon epidermal growth factor and platelet-derived growth factor receptor stimulation and in polyomavirus middle-T-antigen-transformed cells.

Authors:  S B Kanner; A B Reynolds; J T Parsons
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

7.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

Authors:  D P Bottaro; J S Rubin; D L Faletto; A M Chan; T E Kmiecik; G F Vande Woude; S A Aaronson
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

Review 8.  Proliferation and malignant transformation of melanocytes.

Authors:  R Halaban; G Moellmann
Journal:  Crit Rev Oncog       Date:  1991

9.  PDGF, CSF-1, and EGF induce tyrosine phosphorylation of p120, a pp60src transformation-associated substrate.

Authors:  J R Downing; A B Reynolds
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

10.  A specific combination of substrates is involved in signal transduction by the kit-encoded receptor.

Authors:  S Lev; D Givol; Y Yarden
Journal:  EMBO J       Date:  1991-03       Impact factor: 11.598

View more
  35 in total

Review 1.  Pigmented human skin equivalent--as a model of the mechanisms of control of cell-cell and cell-matrix interactions.

Authors:  K Nakazawa; M Kalassy; F Sahuc; C Collombel; O Damour
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

2.  Inhibition of c-Jun DNA binding by mitogen-activated protein kinase.

Authors:  S Y Chou; V Baichwal; J E Ferrell
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

Review 3.  Molecular biology of adenoid cystic carcinoma.

Authors:  Jia Liu; Chunbo Shao; Marietta L Tan; David Mu; Robert L Ferris; Patrick K Ha
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

Review 4.  Molecular targets in melanoma: time for 'ethnic personalization'.

Authors:  Shane Y Morita; Svetomir N Markovic
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

Review 5.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

6.  Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.

Authors:  B J Longley; D D Metcalfe; M Tharp; X Wang; L Tyrrell; S Z Lu; D Heitjan; Y Ma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

7.  Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

Authors:  H Nagata; A S Worobec; C K Oh; B A Chowdhury; S Tannenbaum; Y Suzuki; D D Metcalfe
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

8.  Phenotypic characterization of skin lesions in urticaria pigmentosa and mastocytomas.

Authors:  N Haas; K Hamann; J Grabbe; B Algermissen; B M Czarnetzki
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 9.  The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others.

Authors:  S J Galli; M Tsai; B K Wershil
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

Review 10.  An overview of chronic urticaria.

Authors:  Vincent S Beltrani
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.